$ARTH Arch Therapeutics Reports AC5 Topical Hemostatic

$ARTH Arch Therapeutics Reports AC5 Topical Hemostatic Device Meets Primary and Secondary Endpoints in First C https://t.co/Rxd9B5S4zi